Key result
Sitagliptin treatment (5 mg/kg/day) significantly decreased serum urea nitrogen, creatinine, and oxidative stress markers compared to the renal ischemia reperfusion control group in rats.
Why the study?
Does sitagliptin prevent renal damage induced by renal ischemia reperfusion in rats?
RCT (n=32)
randomly divided
Does sitagliptin prevent renal damage induced by renal ischemia reperfusion in rats?
Sitagliptin pretreatment ameliorates renal damage induced by ischemia-reperfusion injury in a rat model.
Does not support clinical use; leaves open translation of sitagliptin renoprotection to human ischemia-reperfusion AKI.
This study was designed to investigate the protective effects of sitagliptin on renal damage induced by renal ischemia reperfusion (I/R) in rats. For this, rats were randomly divided into four groups (n = 8): (1) sham group, in which the rats only underwent right nephrectomy; (2) right nephrectomy and left kidney ischemia (1 h) and reperfusion (24 h) group (I/R); (3) 5 mg/kg sitagliptin administrated group, per-oral once a day for two weeks; (4) 5 mg/kg sitagliptin administrated group, per-oral once a day for two weeks before left kidney I/R (n = 8). Sitagliptin-treated rats that underwent renal I/R demonstrated significant decrease in the serum urea nitrogen and creatinine and also, lipid peroxidation, total oxidant status and malondialdehyde level in the renal tissue when compared to the renal I/R group. Additionally, reduced glutathione, glutathione peroxidase, superoxide dismutase, catalase and total antioxidative capacity were significantly increased after renal I/R in sitagliptin-treated rats. Our histopathological findings were in accordance with these biochemical results. In sum, in the current study all of our results indicated that sitagliptin treatment ameliorated renal damage induced by renal I/R in rats.
No takes yet. Share an insight, caveat, or question.
Beytur et al. (2015) conducted an RCT in Renal ischemia reperfusion injury (n=32). Sitagliptin vs. Renal ischemia reperfusion (I/R) without sitagliptin was evaluated on Renal damage (serum urea nitrogen, creatinine, and oxidative stress markers). Sitagliptin treatment (5 mg/kg/day) significantly decreased serum urea nitrogen, creatinine, and oxidative stress markers compared to the renal ischemia reperfusion control group in rats.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: